CompuMed, Inc. Announces New Contract with Wexford Health Sources to Provide Remote ECG Screening to Correctional Sites in Mississippi.

Renewals Also Secured with Oklahoma DOC and Texas Tech

LOS ANGELES -- CompuMed, Inc. (OTCBB:CMPD) -- a medical informatics company serving the healthcare community and leading the development of advanced imaging and medical informatics to provide cost-effective analysis and monitoring -- today announced three agreements that extend its dominance as the leading provider of electrocardiogram (ECG) remote interpretation systems and services for correctional institutions.

The agreements include a new three-year statewide contract in conjunction with Wexford Health Sources, Inc. to provide electrocardiogram (ECG) remote interpretation systems and services for the Mississippi Department of Corrections. Under the terms of the agreement, CompuMed's CardioGram system will perform remote cardiac screening for detainees at two of the state's main correctional facilities as well as at 11 County Regional facilities. CompuMed is a preferred value-added partner of Pittsburgh-based Wexford Health Sources, which provides comprehensive healthcare services for correctional system clients nationwide. CompuMed now services Wexford facilities in three states.

"We are pleased to further expand our successful partnership with Wexford Health Sources," said Jerry McLaughlin, CompuMed's CEO. "Providing quality healthcare services for correctional facilities while containing costs is a challenge, especially given the aging prison population. We look forward to helping correctional clients continue to meet this challenge with additional services in the future."

In addition to the new Mississippi/Wexford contract, CompuMed renewed contracts with state correctional clients in Oklahoma and Texas. Under the terms of the Oklahoma Department of Corrections (OKDOC) contract extension, CompuMed will provide remote cardiac screening on an as-needed basis for more than 14,000 detainees at all 20 of the Department's facilities. Under the terms of the new two-year Texas Tech University Health Sciences Center agreement, CompuMed will provide interpretative ECG services to 10 correctional facilities. These three agreements are estimated to total more than $143,000 in annual revenue.

"We are pleased that our state correctional partners continue to renew their agreements with CompuMed," Jerry McLaughlin added. "Our ECG business is a recurring revenue model. Providing these types of services is a competency that we plan to leverage and expand in the coming months in concert with our complementary analysis technology."

The CompuMed system significantly reduces healthcare costs by providing remote cardiac screening at the point of care. Another key advantage is an optional feature that automatically sends ECG results to a trained cardiologist for an over-read when the results are abnormal.

About CompuMed

CompuMed, Inc. (OTCBB:CMPD) is leading the development of advanced imaging and medical informatics to provide cost-effective analysis and monitoring solutions. The Company focuses on cardiovascular and muscular skeletal diseases and other diseases associated with aging populations. The Company has unique expertise in telemonitoring, imaging and analysis which it is deploying to provide solutions and services designed to improve the workflow of healthcare providers, improve patient's care and reduce costs. The Company's core products are the OsteoGram[R] and CardioGram systems. The OsteoGram, which is cleared by the FDA for commercial use, is an accurate and precise technology for cost-effective osteoporosis testing. The CardioGram system remotely interprets electrocardiograms and is used by private practice, government and corporate healthcare providers nationwide. CompuMed is headquartered in Los Angeles. Visit CompuMed at www.compumed.net or call 310-258-5000.

This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning CompuMed's plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements that are not statements of historical fact. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, ability to raise capital, the availability of appropriate acquisition candidates and/or business partnerships, economic conditions, the impact of competition and pricing, capacity and supply constraints or difficulties, government regulation and other risks identified in the Company's filings with the Securities and Exchange Commission. All such forward-looking statements are expressly qualified by these cautionary statements. In addition, the Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof, except as required by law.